Is EYES or DIVO a better dividend investment in 2026?

EYES currently yields 48.31% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: EYES offers higher current income.

What is the dividend yield difference between EYES and DIVO?

EYES has a forward dividend yield of 48.31% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 41.82 percentage points.

Home › Compare › EYES vs DIVO

EYES vs DIVO: Dividend Comparison 2026

EYES yields 48.31% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EYES wins by $330.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

EYES

● Live price

48.31%

Share price

$4.14

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$360.9K

Annual income

$71,162.95

Full EYES calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — EYES vs DIVO

📍 EYES pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EYES	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EYES + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EYES pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EYES

Annual income on $10K today (after 15% tax)

$4,106.28/yr

After 10yr DRIP, annual income (after tax)

$60,488.51/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, EYES beats the other by $59,654.08/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EYES + DIVO for your $10,000?

EYES: 50%DIVO: 50%

100% DIVO50/50100% EYES

Portfolio after 10yr

$195.8K

Annual income

$36,072.31/yr

Blended yield

18.42%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EYES right now

EYES

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-1.9

Piotroski

3/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EYES buys

DIVO buys

No recent congressional trades found for EYES or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEYESDIVO

Forward yield	48.31% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$360.9K ✓	$30.7K
Annual income after 10y	$71,162.95 ✓	$981.68
Total dividends collected	$285.6K ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: EYES vs DIVO ($10,000, DRIP)

Year	EYES Portfolio	EYES Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$15,531	$4,830.92	$11,349	$649.42	+$4.2K → EYES
2	$23,630	$7,012.02	$12,833	$688.83	+$10.8K → EYES
3	$35,255	$9,970.75	$14,459	$727.90	+$20.8K → EYES
4	$51,625	$13,902.68	$16,238	$766.49	+$35.4K → EYES
5	$74,266	$19,026.49	$18,179	$804.47	+$56.1K → EYES
6	$105,044	$25,579.93	$20,293	$841.71	+$84.8K → EYES
7	$146,212	$33,814.22	$22,591	$878.14	+$123.6K → EYES
8	$200,433	$43,987.07	$25,087	$913.65	+$175.3K → EYES
9	$270,818	$56,354.64	$27,791	$948.18	+$243.0K → EYES
10	$360,939	$71,162.95	$30,718	$981.68	+$330.2K → EYES

EYES vs DIVO: Complete Analysis 2026

EYES — Stock

As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.

Full EYES Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this EYES vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EYES vs SCHD EYES vs JEPI EYES vs O EYES vs KO EYES vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.